The role of IL-21 in regulating B-cell function in health and disease

被引:188
作者
Ettinger, Rachel [1 ]
Kuchen, Stefan [1 ]
Lipsky, Peter E. [1 ]
机构
[1] NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA
关键词
IL-21; cytokines; human; autoimmunity; B cells; humoral immunity;
D O I
10.1111/j.1600-065X.2008.00631.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-21 (IL-21) belongs to a family of cytokines that includes IL-2, IL-4, IL-7, IL-9, and IL-15, all of which bind to private (or shared) receptors as well as the common cytokine receptor gamma-chain as a component. Most cytokines in this family are critically important for both the maintenance and function of T cells and B cells. The receptor for IL-21 is widely distributed on lymphohematopoietic cells, and IL-21 plays many biologic roles, including maintenance and function of CD8(+) memory T cells and natural killer cells, as well as promoting the generation of Th17 cells in the mouse. One principal non-redundant role of IL-21 is the promotion of B-cell activation, differentiation or death during humoral immune responses. Furthermore, increased IL-21 production is characteristic of certain autoimmune diseases and is likely to contribute to autoantibody production as well as pathologic features of autoimmune disease. In contrast, IL-21 may function as a co-adjuvant to enhance antibody responses and thereby facilitate host defense to malignances and infectious diseases. The critical role of IL-21 in promoting humoral immune responses makes it an important focus of potential therapeutic interventions in conditions characterized by either overproduction of pathogenic autoantibodies or under production of protective antibodies.
引用
收藏
页码:60 / 86
页数:27
相关论文
共 157 条
[1]   Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells [J].
Acosta-Rodriguez, Eva V. ;
Napolitani, Giorgio ;
Lanzavecchia, Antonio ;
Sallusto, Federica .
NATURE IMMUNOLOGY, 2007, 8 (09) :942-949
[2]   High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma [J].
Akamatsu, Norihiko ;
Yamada, Yasuaki ;
Hasegawa, Hiroo ;
Makabe, Koki ;
Asano, Ryutaro ;
Kumagai, Izumi ;
Murata, Ken ;
Maizum, Yoshitaka ;
Tsukasaki, Kunihiro ;
Tsuruda, Kazuto ;
Sugahara, Kazuyuki ;
AtogaMi, Sunao ;
Yanagihara, Katsunori ;
Kamihira, Shimeru .
CANCER LETTERS, 2007, 256 (02) :196-206
[3]   Phenotypic and functional features of human Th17 cells [J].
Annunziato, Francesco ;
Cosmi, Lorenzo ;
Santarlasci, Veronica ;
Maggi, Laura ;
Liotta, Francesco ;
Mazzinghi, Benedetta ;
Parente, Eliana ;
Fili, Lucia ;
Ferri, Simona ;
Frosali, Francesca ;
Giudici, Francesco ;
Romagnani, Paola ;
Parronchi, Paola ;
Tonelli, Francesco ;
Maggi, Enrico ;
Romagnani, Sergio .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1849-1861
[4]   Memory B cells are biased towards terminal differentiation: A strategy that may prevent repertoire freezing [J].
Arpin, C ;
Banchereau, J ;
Liu, YJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) :931-940
[5]   Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes [J].
Asano, Katsuaki ;
Ikegami, Hiroshi ;
Fujisawa, Tomomi ;
Nishino, Masanori ;
Nojima, Koji ;
Kawabata, Yumiko ;
Noso, Shinsuke ;
Hiromine, Yoshihisa ;
Fukai, Aya ;
Ogihara, Toshio .
HUMAN IMMUNOLOGY, 2007, 68 (05) :384-391
[6]   BAFF selectively enhances the survival of plasmablasts generated from human memory B cells [J].
Avery, DT ;
Kalled, SL ;
Ellyard, JI ;
Ambrose, C ;
Bixler, SA ;
Thien, M ;
Brink, R ;
Mackay, F ;
Hodgkin, PD ;
Tangye, SG .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (02) :286-297
[7]   Maintenance of serological memory by polyclonal activation of human memory B cells [J].
Bernasconi, NL ;
Traggiai, E ;
Lanzavecchia, A .
SCIENCE, 2002, 298 (5601) :2199-2202
[8]   Interleukin-21 inhibits dendritic cell activation and maturation [J].
Brandt, K ;
Bulfone-Paus, S ;
Foster, DC ;
Rückert, R .
BLOOD, 2003, 102 (12) :4090-4098
[9]   Interleukin-21 is a growth and survival factor for human myeloma cells [J].
Brenne, AT ;
Ro, TB ;
Waage, A ;
Sundan, A ;
Borset, M ;
Hjorth-Hansen, H .
BLOOD, 2002, 99 (10) :3756-3762
[10]  
BRIERE F, 1995, ADV EXP MED BIOL, V371, P21